A carregar...
Pharmacoeconomy of drugs used in the treatment of actinic keratoses
Actinic keratosis (AK) represents an emerging issue in the area of skin diseases which undergo high risk for developing squamous cell carcinoma (SCC). Recently, evidence has been accumulated that 3% diclofenac sodium and ingenol mubetate may efficiently counteract the development of progressive AK e...
Na minha lista:
| Publicado no: | Int J Immunopathol Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806840/ https://ncbi.nlm.nih.gov/pubmed/27207444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0394632016648707 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|